BQ 1.1 & BQ.1 subvariant clades look like they will supplant BA.5 by December as new dominant sub-variants with BF.7 coming strong; point is BA.5 EUA bivalent boosters will likely be DOA, WON'T work

by Paul Alexander

Dead on arrival, will go to negative efficacy, effectiveness territory, with viral immune escape, original antigenic sin, and antibody-dependent enhancement of infection (ADEI) & disease (ADED)